Business ❯ Pharmaceutical Industry

Stock Market

Company Performance Investor Reactions Pharmaceutical Stocks Investor Sentiment Market Reactions Vaccine Manufacturers Investors Clinical Trial Results Moderna Global Markets Corporate Competition Health Stocks Company News Biotechnology Stocks Vaccine Development Eli Lilly Kenvue Market Capitalization Karuna Therapeutics Shares

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

Remibrutinib’s superior late‑stage results open a regulatory path for a new oral therapy for relapsing MS.

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Lilly Combo of Zepbound and Taltz Tops Taltz Alone in Late-Stage Psoriasis Trials

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Bristol Myers and J&J Halt Milvexian Heart-Attack Trial After Futility Finding

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug